定量MRI腱鞘炎体积解释抗CCP阳性高危人群肌腱受累与未来临床关节炎的关联
本研究纳入223例无临床滑膜炎的抗CCP阳性有肌肉骨骼症状个体,基线行手和腕对比增强MRI并定量腱鞘炎体积(TSV)和关节滑膜炎体积(SV)。中位随访13.3个月,67例(30%)进展为炎症性关节炎;TSV独立预测进展且优于SV,提示定量TSV评估可优化风险分层。
要点
- 抗CCP阳性无临床滑膜炎个体中,基线MRI腱鞘炎体积(TSV)独立预测炎症性关节炎进展。
- TSV在ROC分析中优于关节滑膜炎体积(AUC 0.697 vs 0.582)。
核心结论
- MRI衍生的腱鞘炎体积(TSV)独立预测抗CCP阳性高危个体的炎症性关节炎进展,且预测效能优于关节滑膜炎体积(SV)。
研究设计与样本
- 纳入223例有肌肉骨骼症状但无临床滑膜炎的抗CCP阳性个体,基线行手和腕对比增强MRI,手动分割和三维重建定量TSV和SV,随访中位13.3个月,以≥1个临床肿胀关节定义炎症性关节炎进展,采用Cox回归和ROC分析。
主要发现
- 223例中67例(30%)在中位13.3个月随访期间进展为炎症性关节炎。
- 基线腱鞘炎(34.5%)与进展相关(P < .001)。
- 进展者TSV高于非进展者(1607 vs 705 mm³,P = .003)。
- 调整SV后TSV仍具预测性(P = .008),ROC分析中TSV优于SV(AUC = 0.697 vs 0.582)。
- 多变量分析中,TSV(P < .001)和压痛关节计数(P = .014)独立预测进展;总炎症体积越高,进展时间越短(P = .008)。
临床怎么用
- 对无临床滑膜炎的抗CCP阳性高危个体,可考虑定量MRI腱鞘炎体积评估以辅助风险分层和预防策略制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tenosynovitis is a key imaging feature in the preclinical phase of rheumatoid arthritis. Prior studies suggest that presence of magnetic resonance imaging (MRI) tenosynovitis may better predict future clinical arthritis than MRI synovitis. We hypothesised that the volume of subclinical inflammation within tendon sheaths may explain this association in anti-cyclic citrullinated peptide (anti-CCP) positive at-risk individuals. This study sought to assess whether MRI-derived tenosynovitis (TSV) and joint synovitis (SV) volumes predict inflammatory arthritis (IA) in anti-CCP-positive individuals without clinical synovitis, beyond clinical/serological markers. METHODS: We included 223 anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis. All underwent baseline contrast-enhanced MRI of the hand and wrist. TSV and SV were quantified via manual segmentation and three-dimensional (3D) reconstruction (OsiriX-MD). IA progression was defined as ≥1 clinically swollen joint. Cox regression and receiver operating characteristic (ROC) analyses were performed. RESULTS: Of 223 participants, 67 (30%) developed IA over a median 13.3-month follow-up. Inter-reader agreement for volumetric scoring was excellent (intraclass correlation coefficient > 0.90 across all regions). Baseline tenosynovitis (34.5%) was associated with progression (P < .001). TSV was higher in progressors than non-progressors (1607 vs 705 mm³, P = .003), remained predictive after adjusting for SV (P = .008), and outperformed SV in ROC analysis (area under curve (AUC) = 0.697 vs 0.582). In multivariable analysis, TSV (P < .001) and tender joint count (P = .014) independently predicted progression beyond clinical and serological markers. Higher total inflammation volume correlated with shorter time to progression (P = .008). CONCLUSIONS: MRI-derived TSV independently predicts IA and outperforms SV. Quantitative TSV assessment may enhance risk stratification and support preventive strategies in at-risk individuals.
引用
- Abacar K, Tabuchi Y, Di Matteo A, et al. Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals. Ann Rheum Dis. 2026. PMID: 41813507. doi:10.1016/j.ard.2025.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。